ArticleEuropean journal of clinical pharmacology2022

Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?

Lixin Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.